Limenbio

1 known investors

Limenbio develops gas-based preservation technology (branded HIPPER) for keeping viable cell grafts, tissues, and organs — including red blood cells, skin grafts, and hearts — using a modified gas atmosphere. Its methods target biomedical and transplantation applications such as extended organ and cell preservation prior to transplant.